Site icon OncologyTube

Using Epigenetic Therapy to Enhance Immunotherapy Response in RCC

Leigh Ellis Department of Oncologic Pathology Dana-Farber Cancer Institute Harvard Medical School presents Using Epigenetic Therapy to Enhance Immunotherapy Response in RCC

Filmed at the 18th International Kidney Cancer Symposium 2019, Miami, FL.

Advertisement
Exit mobile version